[
  {
    "ts": null,
    "headline": "3 Unstoppable Dividend Stocks to Buy Right Now",
    "summary": "Investors will get great dividends and more with these stocks.",
    "url": "https://finnhub.io/api/news?id=259428b71e25776a029cb92d302be440f6d92e0e9af664da0ca96d4208a8c484",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1755945900,
      "headline": "3 Unstoppable Dividend Stocks to Buy Right Now",
      "id": 136496046,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ABBV",
      "source": "Yahoo",
      "summary": "Investors will get great dividends and more with these stocks.",
      "url": "https://finnhub.io/api/news?id=259428b71e25776a029cb92d302be440f6d92e0e9af664da0ca96d4208a8c484"
    }
  },
  {
    "ts": null,
    "headline": "AbbVie Investors Beware: Strong Growth Potential, Rising Risks",
    "summary": "AbbVie has delivered strong returns and dividend growth, with solid prospects but notable risks creating near-term uncertainty. Find out why ABBV stock is a hold.",
    "url": "https://finnhub.io/api/news?id=beb42c238e86ccc8b645ab5ead46daf2d5038084636cc09524e5d395d77f7f9f",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1755945076,
      "headline": "AbbVie Investors Beware: Strong Growth Potential, Rising Risks",
      "id": 136494470,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1491476609/image_1491476609.jpg?io=getty-c-w1536",
      "related": "ABBV",
      "source": "SeekingAlpha",
      "summary": "AbbVie has delivered strong returns and dividend growth, with solid prospects but notable risks creating near-term uncertainty. Find out why ABBV stock is a hold.",
      "url": "https://finnhub.io/api/news?id=beb42c238e86ccc8b645ab5ead46daf2d5038084636cc09524e5d395d77f7f9f"
    }
  },
  {
    "ts": null,
    "headline": "JonesTrading Lifts Aldeyra Therapeutics, Inc. (ALDX) Price Target to $9",
    "summary": "Aldeyra Therapeutics, Inc. (NASDAQ:ALDX) is among the best US stocks under $10 to invest in. Catherine Novack, an analyst at JonesTrading, has raised the price target on Aldeyra Therapeutics, Inc. (NASDAQ:ALDX) to $9.00 from $6.00, while reaffirming a Buy rating on the stock. This potential upside of about 66.98% from the current price reflects the […]",
    "url": "https://finnhub.io/api/news?id=09ebd15b9cb4699c59854097aab07e1ffbaf2678376180750af54cb341126033",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1755937244,
      "headline": "JonesTrading Lifts Aldeyra Therapeutics, Inc. (ALDX) Price Target to $9",
      "id": 136496047,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ABBV",
      "source": "Yahoo",
      "summary": "Aldeyra Therapeutics, Inc. (NASDAQ:ALDX) is among the best US stocks under $10 to invest in. Catherine Novack, an analyst at JonesTrading, has raised the price target on Aldeyra Therapeutics, Inc. (NASDAQ:ALDX) to $9.00 from $6.00, while reaffirming a Buy rating on the stock. This potential upside of about 66.98% from the current price reflects the […]",
      "url": "https://finnhub.io/api/news?id=09ebd15b9cb4699c59854097aab07e1ffbaf2678376180750af54cb341126033"
    }
  }
]